Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF 7/182(R)-6

British Journal of Cancer

Volumn 79, Issue 3-4, 1999, Pages 386-392

  Jensen, B L ^a   Skouv, J ^a   Lundholt, B K ^a   Lykkesfeldt, A E ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Anti oestrogen resistance; Breast cancer; Gene expression; Oestrogen receptor; Progesterone receptor

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; PROGESTERONE RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; PROTEIN BINDING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032945122     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690061     Document Type: Article

References (33)

1. CO and MCF-7 breast cancer cells. Mol Endocrinol 3: 22-28
2. Berthois Y, Dong XF, Roux-Dossetto M and Martin PM (1990) Expression of estrogen receptor and its messenger ribonucleic acid in the MCF-7 cell line: multiparametric analysis of its processing and regulation by estradiol. Mol Cell Endocrinol 74: 11-20
3. Borrás M, Hardy L, Lempereue F, El Khissiin AH, Legros N, Gol-Winkler R and Leclercq G (1994) Estrogen-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48: 325-336
4. Borrás M, Laios I, El Khissiin A, Seo HS, Lempereur F, Legros N and Leclercq G (1996) Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 57: 203-213
5. Briand P and Lykkesfeldt AE (1984) Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to grow at low serum concentration. Cancer Res 44: 1114-1119
6. Clarke R and Brünner N (1996) Acquired estrogen independence and antiestrogen resistance in breast cancer. Estrogen receptor driven phenotypes? Trends Endocrinol Metab 7: 291-301
7. Dauvois S, Danielian PS, White R and Parker MG, (1992) Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89: 4037-4041
8. EORTC Breast Co-operative Group (1980) Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second EORTC workshop. held on 16-17 March, 1979, in the Netherlands Cancer Institute. Eur J Cancer 16: 1513-1515
9. Gibson MK, Nemmers LA, Beckman WC, Davis VL, Curtis SW and Korack KS (1991) The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of ER in uterine tissue. Endocrinology 129: 2000-2010
10. Herman ME and Katzenellenbogen BS (1996) Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. J Steroid Biochem Mol Biol 59: 121-134
11. Horwitz KB and McGuire WL (1978) Nuclear mechanisms of estrogen action. J Biol Chem 253: 8185-8191
12. Howell A, DeFriend DJ, Robertson JFR, Blamey RW and Walton P (1995) Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. Lancet 345: 29-30
13. Hyder SM, Chiappetta C, Murthy L and Stancel GM (1997) Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res 57: 2547-2549
14. Johnston SRD, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR and Dowsett M (1995) Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55: 3331-3338
15. Katzenellenbogen BS (1991) Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J Natl Cancer Inst 83: 1434-1444
16. Laborda J (1991) 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19: 3998
17. Larsen SS, Madsen MW, Jensen BL and Lykkesfeldt AE (1997) Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness. Int J Cancer 72: 1129-1136
18. Liang P and Pardee AB (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-970
19. Lykkesfeldt AE (1996) Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer. Acta Oncol 35: 9-14
20. R-1. Cancer Res 54: 1587-1595
21. Lykkesfeldt AE, Larsen SS and Briand P (1995) Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment. Int J Cancer 61: 529-534
22. R-1 compared to the parental MCF-7 cell line. Mol Cell Endocrinol 109: 197-207
23. Masamura S, Santner SJ, Heitjan DF and Santen RJ (1995) Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80: 2918-2925
24. Mouridsen H, Palshof T, Patterson J and Battersby L (1978) Tamoxifen in advanced breast cancer. Cancer Treat Rev 5: 131-141
25. Osborne CK, Yochmowitz MG, Knight WA and McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884-2888
26. Osborne CK, Coronado-Heinsohn EB, Hilsenbeck SG, McCue BL, Wakeling AE, McClelland RA, Manning DL and Nicholson RI (1995) Comparison of the effects of pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J Natl Cancer Inst 87: 746-750
27. Pink JJ and Jordan VC (1996) Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321-2330
28. Robertson JFR (1996) Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 73: 5-12
29. Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmongkol M, Puente M and Martin MB (1988) Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2: 1157-1162
30. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E and Chambon P (1989) The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59: 477-487
31. van Agthoven T, van Agthoven TLA, Dekker A, Foekens JA and Dorssers LCJ (1994) Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations. Mol Endocrinol 8: 1474-1483
32. Wakeling AE, Dukes M and Bowler J (1991) A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873
33. Wakeling AE (1993) Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens? J Steroid Biochem Mol Biol 47: 107-111